Clinical Trials
3 trialsNCT03122249 2024-05-08
OASIS
University of Iowa
Phase NA Withdrawn
NCT05262842 2022-09-21
JS001+IMP4297 in Patients With Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Withdrawn
NCT02432612 2016-03-02
A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer
GWPharm
Phase 1 Withdrawn